| 1 |
[GO] |
2024―Jul―30 |
Adverse events associated with SARS-CoV-2 neutralizing monoclonal antibodies using the FDA adverse event reporting system database |
Min Joung Choi, Se-Hun Oh, Yun-Kyoung Song, Sung Hwan Ki |
| 2 |
[GO] |
2021―Jul―19 |
A review on the pharmacokinetic properties and toxicity considerations for chloroquine and hydroxychloroquine to potentially treat coronavirus patients |
Fatemeh Askarian, Zahra Firoozi, Alireza Ebadollahi-Natanzi, Solmaz Bahrami, Hamid-Reza Rahimi |